"XBB" の関連情報検索結果

AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI



AI Investing Insights - Official Homepage - Intellectia AI™  Intellectia AI

Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk asses...



Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk assessment  Nature

(XBB) Movement as an Input in Quant Signal Sets - Stock Traders Daily



(XBB) Movement as an Input in Quant Signal Sets  Stock Traders Daily

Review Affirms Safety and Effectiveness of COVID-19, RSV, and Influenza Vaccines - Optometry Advisor



Review Affirms Safety and Effectiveness of COVID-19, RSV, and Influenza Vaccines  Optometry Advisor

The World's First Fixed Income ETFs Turn 25 - ETF Trends



The World's First Fixed Income ETFs Turn 25  ETF Trends

Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, Octobe...



Durability of the BNT162b2 XBB.1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform  medRxiv

XBB Should I Buy - Intellectia AI



XBB Should I Buy  Intellectia AI

Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...



Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study  Nature

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance - News-Medical



New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance  News-Medical

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke School of Medicine



Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design  Duke School of Medicine

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)



TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization (WHO)

Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine booste...



Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine boosters in preventing fatal outcomes among severe COVID-19 cases during the current ambit of SARS-CoV-2 XBB and JN.1 variant circulation  Frontiers

XBB Forecast — Price Prediction for 2026. Should I Buy XBB? - Intellectia AI



XBB Forecast — Price Prediction for 2026. Should I Buy XBB?  Intellectia AI

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection - ...



Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection  Nature

AI Investing Insights - Official Homepage - Intellectia AI™ - Intellectia AI



AI Investing Insights - Official Homepage - Intellectia AI™  Intellectia AI

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-1...



Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination  Nature

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...



Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies  Nature

XBB Technical Analysis & Stock Price Forecast - Intellectia AI



XBB Technical Analysis & Stock Price Forecast  Intellectia AI

XBB Technical Analysis & ETF Price Forecast - Intellectia AI



XBB Technical Analysis & ETF Price Forecast  Intellectia AI

Humoral immunity and clinical characteristics of Chinese college students experiencing a BA.5/BF....



Humoral immunity and clinical characteristics of Chinese college students experiencing a BA.5/BF.7 and XBB.1.5 wave  Nature

XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight - Seeking Alpha



XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight  Seeking Alpha

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...



What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association



XBB.1.5 Omicron subvariant: Questions patients may have  American Medical Association

Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster - The New England Jo...



Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster  The New England Journal of Medicine

Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine



Durability of XBB.1.5 Vaccines against Omicron Subvariants  The New England Journal of Medicine

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...



Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines  Nature

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature



Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant  Nature

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature



Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System  Nature

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...



Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion  Nature

Here’s what we know about the new Omicron variant XBB.1.5 - Gavi, the Vaccine Alliance



Here’s what we know about the new Omicron variant XBB.1.5  Gavi, the Vaccine Alliance

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...



Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants  Nature

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 - Nature



Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1  Nature

What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS



What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant  PBS

Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity | npj Vacc...



Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity | npj Vaccines  Nature

COVID-19 Vaccines Should Be Monovalent and Contain the XBB Strain, FDA Committee Recommends - Con...



COVID-19 Vaccines Should Be Monovalent and Contain the XBB Strain, FDA Committee Recommends  Contagion Live

Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine



Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know  Yale Medicine

Not just Singapore: The highly immune-evasive XBB COVID variant has been identified in 26 countri...



Not just Singapore: The highly immune-evasive XBB COVID variant has been identified in 26 countries, the WHO says  Fortune

XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant - UC Davis



XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant  UC Davis

Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story ci...



Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story circulating again  Africa Check

The rise of variant XBB.1.5, and more — this week’s best science graphics - Nature



The rise of variant XBB.1.5, and more — this week’s best science graphics  Nature

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...



Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  The New England Journal of Medicine

WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries - CIDRAP



WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries  CIDRAP

The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of...



The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of a few cases  Frontiers

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - The New England Journal...



Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB  The New England Journal of Medicine

Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” - Gavi, the Vaccine Alliance



Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest”  Gavi, the Vaccine Alliance

XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...



XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants | Scientific Reports  Nature

Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic News Network



Rising cases of COVID-19 variant, XBB.1.5  Mayo Clinic News Network

Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein va...



Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study  The Lancet

WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency - CIDRAP



WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency  CIDRAP

Characteristics of the omicron XBB subvariant wave in Singapore - The Lancet



Characteristics of the omicron XBB subvariant wave in Singapore  The Lancet

XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such a...



XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies | mBio  ASM Journals

FDA panel backs monovalent XBB switch for fall COVID vaccines - CIDRAP



FDA panel backs monovalent XBB switch for fall COVID vaccines  CIDRAP

ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5 - The Lancet



ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5  The Lancet

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...



Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials  Nature

Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 ...



Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein  Nature

Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do...



Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul  Nature

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - CIDRAP



XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids  CIDRAP

Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant - Nature



Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant  Nature

COVID variant XBB.1.5 may be poised to sweep Michigan: What to know - BridgeDetroit



COVID variant XBB.1.5 may be poised to sweep Michigan: What to know  BridgeDetroit

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...



Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates  Nature

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)



Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

WHO issues initial Omicron XBB.1.16 risk assessment - CIDRAP



WHO issues initial Omicron XBB.1.16 risk assessment  CIDRAP

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...



Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation | Scientific Reports  Nature

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biol...



Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biology  Nature

Updated COVID-19 Boosters and XBB.1.5: What You Need to Know - American Society for Microbiology



Updated COVID-19 Boosters and XBB.1.5: What You Need to Know  American Society for Microbiology

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden - The ...



Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden  The Lancet

Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles ...



Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly  CNBC

CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News - American Ho...



CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News  American Hospital Association

Could the “Arcturus” variant trigger a new wave of COVID-19 infections and deaths? - Gavi, the Va...



Could the “Arcturus” variant trigger a new wave of COVID-19 infections and deaths?  Gavi, the Vaccine Alliance

Omicron XBB.1.5 is rising in U.S. though revised CDC data shows slower increase than previously r...



Omicron XBB.1.5 is rising in U.S. though revised CDC data shows slower increase than previously reported  CNBC

XBB.1.16 picks up speed in US as WHO experts weigh COVID vaccine composition - CIDRAP



XBB.1.16 picks up speed in US as WHO experts weigh COVID vaccine composition  CIDRAP

From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more wo...



From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more worrying than others)  The Conversation

The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US – here’s what it could mean for th...



The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US – here’s what it could mean for the UK  The Conversation

XBB.1.5 is rapidly taking over the US. Here's what we know about the new COVID variant - TODAY.com



XBB.1.5 is rapidly taking over the US. Here's what we know about the new COVID variant  TODAY.com

Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 ...



Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023  Nature

WHO advisers weigh in on Omicron XBB and BQ.1 subvariants - CIDRAP



WHO advisers weigh in on Omicron XBB and BQ.1 subvariants  CIDRAP

How the latest Covid-19 variant is shaping the course of the pandemic - Vox



How the latest Covid-19 variant is shaping the course of the pandemic  Vox

WHO advisers recommend switch to monovalent XBB COVID vaccine - CIDRAP



WHO advisers recommend switch to monovalent XBB COVID vaccine  CIDRAP

What is the XBB.1.5 subvariant? CDC reports a new strain of omicron taking over in the U.S. - NBC...



What is the XBB.1.5 subvariant? CDC reports a new strain of omicron taking over in the U.S.  NBC News

Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booste...



Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booster  Nature

Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious - Scientific American



Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious  Scientific American

A new variant alert - Ground Truths | Eric Topol



A new variant alert  Ground Truths | Eric Topol

The Updated COVID-19 Shot Works on the Newest Variants - Time Magazine



The Updated COVID-19 Shot Works on the Newest Variants  Time Magazine

How much should people worry about Covid’s XBB.1.5 variant? Our medical analyst explains - CNN



How much should people worry about Covid’s XBB.1.5 variant? Our medical analyst explains  CNN

Do Coloradans need to care about the new COVID variant XBB? Yeah, probably. - The Colorado Sun



Do Coloradans need to care about the new COVID variant XBB? Yeah, probably.  The Colorado Sun

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines - The New England Journal of Medi...



Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines  The New England Journal of Medicine

Omicron XBB.1.5 variant expands US dominance - CIDRAP



Omicron XBB.1.5 variant expands US dominance  CIDRAP

FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall - CNBC



FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall  CNBC

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infecti...



Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children  Nature

XBB booster offers protection against JN.1 infections, hospital cases, new data show - CIDRAP



XBB booster offers protection against JN.1 infections, hospital cases, new data show  CIDRAP

Arcturus: what to know about the new COVID variant, omicron XBB.1.16 - The Conversation



Arcturus: what to know about the new COVID variant, omicron XBB.1.16  The Conversation

Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...



Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study  The Lancet

What You Need To Know About XBB.1.5, COVID’s Latest Variant - Texas A&M Stories



What You Need To Know About XBB.1.5, COVID’s Latest Variant  Texas A&M Stories

WHO elevates XBB.1.16 to variant of interest as levels rise in US and other countries - CIDRAP



WHO elevates XBB.1.16 to variant of interest as levels rise in US and other countries  CIDRAP

The ‘Kraken’ subvariant XBB.1.5 sounds scary. But behind the headlines are clues to where COVID’s...



The ‘Kraken’ subvariant XBB.1.5 sounds scary. But behind the headlines are clues to where COVID’s heading  The Conversation

Omicron Subvariant XBB.1.5: What to Know - NewYork-Presbyterian - Health Matters



Omicron Subvariant XBB.1.5: What to Know  NewYork-Presbyterian - Health Matters

Effectiveness of XBB.1.5 Vaccines Against Omicron Subvariants - medRxiv



Effectiveness of XBB.1.5 Vaccines Against Omicron Subvariants  medRxiv

Mayo Clinic expert talks about the new omicron variant - Mayo Clinic News Network



Mayo Clinic expert talks about the new omicron variant  Mayo Clinic News Network

Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US - CNN



Omicron offshoot XBB.1.5 could drive new Covid-19 surge in US  CNN

Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage | Cellular & Mo...



Host cell entry and neutralisation sensitivity of the SARS-CoV-2 XBB.1.16 lineage | Cellular & Molecular Immunology  Nature